Global Point Of Care Molecular Diagnostic Market Size and Overview

Market Scenario

The global point of care molecular diagnostic market was valued at USD 1.62 billion in 2018 and t is expected to grow at a healthy CAGR of 6.4% during 2019-2026.

Point of care testing molecular diagnostic is medical diagnostic testing at or near the point of care. Point of care molecular diagnostic test is used to detect infectious disease, genetic diseases and others. During last decades there is a significant increase in the prevalence of chronic diseases which has led to increase in the patient inflow. Point of care test is useful in providing the immediate results to the patient. According to the research conducted by the Johns Hopkins University, in 2012, 1.4 million people were suffering from chronic hepatitis B.

The global point of care molecular diagnostic market is majorly driven by increasing prevalence of the infectious diseases, hematological diseases, cancer, and others. Increasing gove
ment support and increasing healthcare awareness among the people have fuelled the growth of the market. Moreover, growth in biomarker identification and development in molecular diagnostic techniques have supported the growth of the market.

Though there are good opportunities for the growth of the market. To introduce the test and devices into the market the product has to meet the strict gove
ment regulations for devices or test. This stringent gove
ment regulations and poor reimbursement policies may hinder the growth of the market during the forecasted period.

The market is majorly grabbed by developed region, thus the manufacturers can grab the opportunity of the development of the market in developing region.

Segmentation

The global point of care molecular diagnostic market is segmented on the basis of techniques, applications and end users.

On the basis of techniques, the point of care testing molecular diagnostic market is segmented into polymerase chain reaction (PCR), hybridization, DNA diagnostics, microarrays, and others.

On the basis of application, the point of care testing molecular diagnostic market is segmented into infectious diseases, hematology, endocrinology, oncology, and other. Infectious diseases are further segmented into hepatitis B, hepatitis C, HIV, TB, MRSA, and others.

On the basis of end users, the point of care testing molecular diagnostic market is segmented into professional diagnostics laboratories, molecular diagnostics laboratories, and others.

Regional Analysis

On regional basis the global point of care molecular diagnostic market is segmented into America, Europe, Asia Pacific and The Middle East & Africa. America commands for the largest share in the global point of care molecular diagnostic market owing to the huge patient population well developed economy and high healthcare expenditure. According to the National Cancer Institute, in 2016, 1.6 million Americans were suffering from cancer.

Europe commands the second largest share in the market. Strong gove
ment support for research and increasing prevalence of chronic diseases has driven the growth of Europe market. Asia Pacific has the fastest growing market due to the presence of huge opportunity for the development of the market and huge population base in this region.

On the other hand, the Middle East & Africa holds the least share in the point of care testing molecular diagnostic market due to limited development in healthcare technology and poor economy in Africa region.

Key Players

The key players in the point of care testing molecular diagnostic market are: F. Hoffmann-La Roche Ltd (Switzerland), Alere (U.S.), Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Siemens Healthcare GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher (U.S.), QIAGEN (Germany), Johnson & Johnson Services, Inc. (U.S.), and Ortho Clinical Diagnostics (U.S.)

Segmentation

Global Point Of Care Molecular Diagnostic Market By Techniques

Polymerase Chain Reaction (PCR)

Hybridization

DNA Diagnostics

Microarrays

Others

Global Point Of Care Molecular Diagnostic Market By Application

Infectious Diseases

Hepatitis B

Hepatitis C

HIV

TB

MRSA

Others

Hematology

Endocrinology

Oncology

Other

Global Point Of Care Molecular Diagnostic Market By End Users

Professional Diagnostics Laboratories

Molecular Diagnostics Laboratories

Others

Global Point Of Care Molecular Diagnostic Market

F. Hoffmann-La Roche Ltd

Alere

Thermo Fisher Scientific

Abbott Laboratories

Siemens Healthcare GmbH

Bio-Rad Laboratories, Inc.

Becton, Dickinson and Company

Danaher

QIAGEN

Johnson & Johnson Services, Inc.

Ortho Clinical Diagnostics (U.S.)